<DOC>
	<DOCNO>NCT00846963</DOCNO>
	<brief_summary>The purpose study determine whether ursodiol effective treatment parenteral nutrition associate cholestasis neonate .</brief_summary>
	<brief_title>Ursodiol Treating Parenteral Nutrition Associated Cholestasis Neonates</brief_title>
	<detailed_description>This first randomise control study address question role ursodiol treatment case PNAC . It include neonate stratification less equal 32 week 32 week gestation .</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Preterm interm newborn hospitalize neonatal care unit CHU SainteJustine October 1st 2008 October 1st 2011 . Must receive parenteral nutrition ( either partial total ) diagnosis cholestasis . Parental Consent must obtain . Active urinary tract infection Presence clinical sign ( acholic stool ) ultrasound evidence biliary tract anomaly . Positive TORCH infection ( Toxoplasmosis , Other infection , Rubella , Cytomegalovirus , Herpes simplex virus ) Known short bowel syndrome Known congenital hypothyroidism Known genetic disorder associate cholestasis like galactosemia , phenylcytonuria , antitrypsin 1 deficiency ... etc</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>parenteral nutrition associate cholestasis neonate</keyword>
	<keyword>parenteral nutrition induce cholestasis preterms</keyword>
	<keyword>Bile duct obstruction</keyword>
	<keyword>biliary stasis</keyword>
</DOC>